Vidvan Image

Dr Mahesh Radhakrishnan

vidwan id: 31559
Male

Senior Professor, Department of Pharmacy
Birla Institute of Technology and Science

Expertise

  • Neurosciences

Publications

Total Articles 265
Books 0
Proceedings 0

Publications

No publication activity to display at the moment.

Scopus

Citations 1994
h-index 25

CrossRef

CrossRef Icon
Citations 2185
h-index 27
Google Scholar

Loading Scholar statistics...

Professional Recognition

2016

Best Poster 1st Presentation Prize

DBT, ICMR and APTI Sponsored National Conference on “Contemporary Technologies in Drug Delivery and
2014

Best Published Paper Award; Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award (Assoc. of Pharm. Teachers of India Conf. 2014)

Association of Pharmaceutical Teachers of India (APTI)
2013

Best Published Paper Award; NN Dutta Prize (Indian Pharmacology Society Conf. 2013)

Indian Pharmacology Society Conf. 2013
2012

Best Published Paper Award (Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award )

Association of Pharmaceutical Teachers of India (APTI)
2011

Best Published Paper Award (Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award )

Association of Pharmaceutical Teachers of India (APTI)
2014

Best Poster 2nd Presentation Prize

NIPICON International Conference
2012

Best Poster 1st Prize

Pharmanext (AIPER)
2012

Best Poster Presentation Prize

Indian Pharmaceutical Association
2011

Best Poster Presentation 1st Prize

Indian Pharmacological Society International Convention
2009

Best Poster Presentation 1st Prize

Association of Pharmaceutical Teachers of India (APTI), Conference
2008

Best Poster Presentation 1st Prize

Indian Pharmacological Society International Convention
2005

Best Paper Published

Indian Pharmaceutical Congress Annual Convention
2011

PC Dandiya Award

Indian Pharmacological Society International Convention

Community & Membership

No Data Found

There is currently nothing to display here.

Indian Pharmacological Society

2010
Life Time

Association of Pharmaceutial Teachers of India

2010
Life Time

Bio

[I] Drug design & synthesis of; (a) Serotonergic modulators with special emphasis on neurodegenerative disorders (b) Anti-malarial agents [II] Neuro-psychopharmacology; Depression, Anxiety, Alzheimer’s & Parkinson’s Diseases, Cognitive Impairments and Depression Co-morbid with Metabolic Disorders

Personal Details

  • Male
  • Senior Professor , Birla Institute of Technology and Science
  • Birla Institute of Technology and Science, Pilani, Vidya Vihar
Ph.D.
Other Institute 1997
M. Pharm
Other Institute 1989
Senior Professor Nov 2021 – Present
Birla Institute of Technology and Science | Department of Pharmacy
Professor Jan 2010 – Nov 2021
Birla Institute of Technology and Science | Department of Pharmacy
Associate Professor Jan 2005 – Jan 2010
Birla Institute of Technology and Science | Department of Pharmacy
Assistant Professor Jan 2000 – Jan 2005
Birla Institute of Technology and Science | Department of Pharmacy

Related Profiles

Experts (250+)

View All
Abhishek

Mr Abhishek Agarwal

Assistant Professor

Preeti

Dr Preeti Sharma

Assistant Professor

Pavithra

Pavithra Velayutham

Assistant Professor

Mahaboob

Dr Mahaboob Basha

Physical Director

HIBA

HIBA -

Assistant Professor

Muskan

Dr Muskan Jain (PT)

Assistant Professor

Shalini

Ms Shalini Saini

Assistant Professor

Organisations (1053+)

View All

Co-Authors (2)

Shvetank

Dr Shvetank Bhatt

Dr. Vishwanath Karad Mit World Peace University

Thangaraj

Dr Thangaraj Devadoss

Shri Vile Parle Kelavani Mandal`s Institute of Pharmacy, Dhule

Scholarly Work

Design and synthesis development of new class of anti-malarial agents

Funding Agency: DBT sponsored Indo-Canadian Joint Consortium (Phase-II)

BT/IN/ CANADA / 22/ AM/ 2009

21,00,000

2014 - Ongoing

Ongoing
Synthesis and pharmacological evaluation of novel phosphodiesterase 4 inhibitors for their anti-depressant and anxiolytic potential

Funding Agency: DBT

BT/PR12691/Med/30/203/2009

51,69,000

2010 - Ongoing

Ongoing
Design and synthesis development of new class of anti-malarial agents

Funding Agency: DBT sponsored Indo-Canadian Joint Consortium (Phase-I)

BT/IN/ CANADA / 22/ AM/ 2009

36,00,000

2010 - Ongoing

Ongoing
Novel Neuro - Pharmacological Agents for the Treatment of Depression, Anxiety, Cognitive Dysfunction and CCIE: Design, Synthesis and Screening of Potential Serotonergic Modulators

Funding Agency: ICMR

58/11/2006-BMS

31,20,000

2009 - Ongoing

Ongoing

Design Synthesis and pharmacological evaluation of novel serotonergic 5HT3 receptor antagonist as potential agents for the treatment of cancer chemotherapy induced emesis

University Birla Institute of Technology and Science, Pilani
Year 2005

Behavioural Neuropharmacological Studies of Selected Serotonin Type-3 Receptor Antagonists as Potential Anti-depressants

University Birla Institute of Technology and Science, Pilani
Year 2008

Neurobehavioural and Neurochemical Evaluation of Selected Monoaminergic Modulators in Animal Models of Comorbid Depression and Anxiety

University Birla Institute of Technology and Science, Pilani
Year 2011

Novel Quinoxaline Carboxamides: Design, Synthesis And Neuro-Pharmacological Evaluation as Anti-depressants, Anxiolytic And in the Management of Cancer Chemotherapy-Induced Nausea and Vomiting

University Birla Institute of Technology and Science, Pilani
Year 2012

Behavioural and Neuropharmacological Screening of Potential Serotonergic Ligands for Co-morbid Depression, Anxiety and Related Disorders such as Cancer Chemotherapy Induced Nausea and Vomiting (CINV)

University Birla Institute of Technology and Science, Pilani
Year 2015

Design, Synthesis and Pharmacological Evaluation of Novel Phosphodiesterase-IV inhibitors for their Anti-depressant and Anxiolytic Potential

University Birla Institute of Technology and Science, Pilani
Year 2015

Behavioral and Neuropharmacological Screening of Phosphodiesterase4 (PDE4) Inhibitors for Anti-depressant and Anxiolytic Potential

University Birla Institute of Technology and Science, Pilani
Year 2015

Novel Neuro-Pharmacological Agents for the Treatment of Depression, Anxiety, Cognitive dysfunction and Cancer Chemo- Therapy Induced Emesis: Design synthesis and Screening af Potential Serotonergic Modulators

University Birla Institute of Technology and Science, Pilani
Year 2016

Behavioral and neuro-pharmacological screenig of potential serotonergic modulators for depression co-morbid with obesity

University Birla Institute of Technology and Science Pilani
Year 2017

Behavioral and neuro-pharmacological screening of potential serotonergic ligands for the management of depression and anxiety co-morbid with type-1 diabetes mellitus

University Birla Institute of Technology and Science Pilani
Year 2016

Design synthesis and screening of potential anti- malarial agents

University Birla Institute of Technology and Science Pilani
Year 2016

Isolation and charcterization of genetic variants of betacasein protein (A1/A2) and study their impact on early precipitation of osteoporosis

University Birla Institute of Technology and Science Pilani
Year 2019

A METHOD FOR DETERMINING A1/A2 GENOTYPE OF MILCH ANIMALS

BIRLA INSTITUTE OF TECHNOLOGY & SCIENCE (BITS)
PILANI
Engineering and Technology Application No. : 201911018953 Filed : 13-05-2019
Published : 20-11-2020 Published

NON-ENZYMATIC METHOD FOR LARGE SCALE ISOLATION OF ß-CASEIN FROM MILK

BIRLA INSTITUTE OF TECHNOLOGY & SCIENCE (BITS)
PILANI
Chemical Sciences Patent No. : 47/2020 Filed : 13-05-2019
Published : 20-11-2020 Published

PDE4 INHIBITOR COMPOUNDS FOR TREATING ANTI-DEPRESSANT AND ANXIOLYTIC RELATED DISORDERS

BIRLA INSTITUTE OF TECHNOLOGY & SCIENCE (BITS)
PILANI
Medical and Health Sciences Patent No. : 47/2015 Filed : 15-05-2014
Published : 20-11-2015 Granted

Scholarly Publications

High fat diet fed obese rats injected with exogenous corticosterone: an animal model to study depressive-phenotypes associated with obesity

Open Access
conference proceedings
Authors: Kurhe Y, Mahesh R

Antidepressant \& anxiolytic activities of N-(pyridin-3-yl) A novel serotonin type 3 receptor antagonist in behavioural animal models

Open Access
article
Authors: Pandey, Dilip Kumar and Devadoss, Thangraj and Modak, Neha and Mahesh Radhakrishnan

A novel 5HT<inf>3</inf> antagonist 4i (N-(3-chloro-2-methylphenyl)quinoxalin-2-carboxamide) prevents diabetes-induced depressive phenotypes in mice: Modulation of serotonergic system

Open Access
Article

5HT<inf>3</inf> receptors: Target for new antidepressant drugs

Open Access
Review
Authors: Gupta D.;Prabhakar V.;Radhakrishnan M.

Depression-like and anxiogenic-like behaviour of rats following impact traumatic brain injury: A model for comorbid anxiety and depression

Open Access
article
Authors: Pandey, Dilip and Mahesh, Radhakrishnan and Yadav, Shushil and Ramamoorthy Rajkumar

Pyridine-based, microwave-assisted one-pot synthetic protocol for the of ethyl 3-substituted-4-oxo-2-thioxo-1,2,3 4-tetrahydropyrimidine-5-carboxylates

Open Access
article

Antidepressant-and anxiolytic-like effect of novel 5-hydroxytryptamine3 receptor antagonist 2-[4-(3-chlorophenyl) piperazin-1-yl]-1,8-naphthyridine-3-carboxylic acid (7e)-: An approach using rodent behavioral antidepressant and anxiolytic test battery

Open Access
Article

Pyridine-based, microwave-assisted one-pot synthetic protocol for the synthesis of ethyl 3-substituted-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates

Open Access
Article